MedPath

Insulin Detemir and Waist Circumference

Completed
Conditions
Type 2 Diabetes
Registration Number
NCT00714844
Lead Sponsor
University of Roma La Sapienza
Brief Summary

The purpose of the study is to investigate the weight-sparing effect of detemir and assess glycemic control and treatment satisfaction when switching from NPH to detemir, to improve metabolic control.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Duration of type 2 diabetes for at least 12 months
  • BMI <40 kg/m2
  • HbA1c >7.5%
  • Requiring basal insulin replacement and previously treated with NPH insulin
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath